Medeloop, the pioneering medical research platform announces the close of its $15.5 million Series A funding round. Led by global venture capital firm Inovia Capital and supported by significant contributions from Icon Ventures, this investment underscores the strong confidence in Medeloop's mission to revolutionize medical research.

The round also welcomed participation from previous investors General Catalyst and Maven Ventures, as well as new investors including Healthier Capital, Up2 Opportunity Fund, and CFO Advisors each bringing valuable industry expertise to support Medeloop's growth.